Cost-Effective Scaling of Cell Therapies: Vertical-Wheel Bioreactors vs Traditional Systems

This white paper analyzes the economic and operational advantages of Vertical-Wheel bioreactors compared with planar culture systems and conventional stirred-tank bioreactors for cell therapy manufacturing. The document reviews factors influencing manufacturing costs, including expansion efficiency, labor requirements, facility footprint, process scalability, batch reproducibility, and final product quality. Published examples demonstrate higher cell yields, reduced processing steps, lower labor demands, and improved facility utilization through single-use closed-system operation. The paper also discusses how low-shear, homogeneous hydrodynamics support consistent cell growth and preservation of critical quality attributes for sensitive cell types such as induced pluripotent stem cells and mesenchymal stem cells. The analysis positions Vertical-Wheel technology as a scalable option for reducing cost of goods while supporting commercial cell therapy manufacturing.